Eurofarma Laboratorios S.A

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Asthma2 trials
• Obesity2 trials
• COPD1 trial
• Migraine1 trial
• Type 2 diabetes1 trial

Phase

• Phase 36 trials

Status

• Withdrawn4 trials
• Completed2 trials
• Not yet recruiting1 trial

Lead sponsor

• Eurofarma Laboratorios S.A.7 trials

Running trials

• Not yet recruiting

  Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)

  NCT06234345· Phase 3· Eurofarma Laboratorios S.A.· Source

  Contact: Edilene Macedo

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting

Closed trials

• Withdrawn

  iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)

  NCT06560333· Phase 3· Eurofarma Laboratorios S.A.· Source

• Withdrawn

  Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil

  NCT05735431· Phase 3· Eurofarma Laboratorios S.A.· Source

• Withdrawn

  A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight

  NCT05209984· Phase 3· Eurofarma Laboratorios S.A.· Source

• Withdrawn

  Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity

  NCT05209997· Eurofarma Laboratorios S.A.· Source

• Completed

  A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment

  NCT04233190· Phase 3· Eurofarma Laboratorios S.A.· Source

• Completed

  Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of Migraine

  NCT04384367· Phase 3· Eurofarma Laboratorios S.A.· Source